Metronidazole pulsatile - Advancis
Alternative Names: Metronidazole PULSYS™; Pulsatile metronidazole; PULSYS™-enhanced metronidazoleLatest Information Update: 25 Dec 2021
At a glance
- Originator Advancis Pharmaceutical
- Class Antibacterials; Antiprotozoals; Nitroimidazoles; Radiosensitisers; Skin disorder therapies; Small molecules
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 15 May 2007 Discontinued - Phase-I/II for Bacterial infections in USA (PO)
- 20 Aug 2004 Phase-I/II clinical trials in Bacterial infections in USA (PO)